—A retrospective study found an increased risk of schizophrenia in patients with ADHD and at least one other psychiatric comorbidity, with a greater risk in those with multiple comorbidities. These ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kane: I think that ...
Anorexia nervosa (AN) is associated with a 4.5-fold increased risk for mortality — a rate that nearly doubles when AN patients have psychiatric comorbidities. Researchers analyzed data from 14,774 ...
Autism spectrum disorder (10.9% vs 1.0%; OR, 10.67; 95% CI, 6.35-17.91; P .001) and attention-deficit hyperactivity disorder (13% vs 3.4%; OR, 3.9; 95% CI, 3.80-4.08; P .001) are more prevalent among ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More than half of adult patients with IBD had at least ...
Please provide your email address to receive an email when new articles are posted on . Sixty-five percent of participants with chronic migraine self-reported psychiatric conditions. More than half ...
Why do mental health diagnoses so often overlap? New genetic research reveals shared roots and points toward more effective ...
Individuals with ADHD and comorbid substance use disorder were more likely to discontinue medication and less likely to resume therapy.
Approximately 70% of veterans with drug-resistant epilepsy reported diagnosis of at least 1 psychiatric condition, with female patients showing a higher prevalence than male patients. Prevalence of ...
Objective To investigate the relationship between adverse childhood experiences (ACEs) and health outcomes in childhood-onset ...
The American Psychiatric Association’s May 2026 issues of three leading journals present significant research on PTSD, substance use disorders, and innovative psychopharmacologic treatments. Featured ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results